— Know what they know.
Not Investment Advice
Also trades as: HLS.TO (TSX) · $vol 0M

HLTRF OTC

HLS Therapeutics Inc.
1W: -1.4% 1M: +4.2% 3M: -8.3% YTD: -19.8% 1Y: -27.6% 3Y: -37.8% 5Y: -80.8%
$2.75
-0.04 (-1.43%)
 
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Sell · Power 47 · $86.0M mcap · 31M float · 0.0018% daily turnover · Short 70% of daily vol

📊 Key Metrics

TTM
$56M
Revenue
-0.2% YoY
$-9M
Net Income
+43.1% YoY
$18M
Free Cash Flow
+51.1% YoY
80.6%
Gross Margin
-7.9%
Op. Margin
-7.0%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-14.1%
ROA-6.2%
ROIC-4.2%

Valuation

P/E-10.3
P/B1.7
EV/EBITDA7.1

Leverage

Debt/Equity0.76
Current Ratio1.05
Interest Cov.-0.8x

Quality Scores

Piotroski F5/9
Altman Z-1.07
Beneish M-3.56

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms